We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KLRHO:BISTKILER HOLDING A.S. Analysis

Data as of 2026-03-15 - not real-time

TRY 177.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Kiler Holding is trading at TRY 177.5, far below its 20‑day (315.8) and 50‑day (408.9) simple moving averages, signaling a pronounced downtrend despite an RSI of 29.9 that suggests the stock is technically oversold. The MACD remains bearish, with the line sitting below the signal (-77.4 vs -63.7) and a negative histogram, while volatility is extreme at 126.8% 30‑day and the maximum drawdown exceeds 75%. Fundamentally, the company posts solid revenue growth of 38.5% and healthy margins (gross 54%, operating 24%), yet valuation metrics are stretched: a trailing PE of 184.9 versus an industry average of 29.1, a price‑to‑book of 9.7, and a discounted cash‑flow fair value of only TRY 8.2. The balance sheet shows ample cash (TRY 8.4 bn) offset by a high debt‑to‑equity ratio of 7.2, and the firm does not pay dividends, limiting income‑oriented appeal.
Market sentiment appears bullish (Fear‑Greed Index 72.9), but the ultra‑low beta (0.05‑0.14) indicates limited systematic risk, while exposure to Turkey’s macro‑economic environment adds geographic and currency concerns. Given the stark valuation disconnect, high volatility, and leverage, the stock appears overvalued in the short run, though its diversified operations and cash cushion provide some defensive qualities for longer horizons.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • price well below short‑term moving averages
  • bearish MACD and negative histogram
  • extreme overvaluation relative to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • strong revenue growth and solid operating margins
  • substantial cash buffer despite high leverage
  • persistent valuation gap that may require price correction

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • diversified conglomerate exposure across multiple sectors
  • low systematic risk (beta near zero)
  • potential macro‑economic stabilization in Turkey

Key Metrics & Analysis

Financial Health

Revenue Growth38.50%
Profit Margin12.76%
P/E Ratio184.9
ROE4.72%
ROA6.13%
Debt/Equity7.22
P/B Ratio9.7
Op. Cash FlowTRY1.1B
Free Cash FlowTRY218.3M
Industry P/E29.1

Technical Analysis

TrendNeutral
RSI30.0
SupportTRY 155.10
ResistanceTRY 560.50
MA 20TRY 315.80
MA 50TRY 408.93
MA 200TRY 192.02
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueTRY 8.24
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.05
Volatility126.80%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.